EYLEA HD
NDC 61755-051, aflibercept, injection, solution, from Regeneron Pharmaceuticals, Inc.
- Product NDC
- 61755-051
- Status
- Listed
- Labeler
- Regeneron Pharmaceuticals, Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761355
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61755-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AFLIBERCEPT8 mg/.07mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61755-051-01 | 61755005101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-051-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-051-00) |
| 61755-051-51 | 61755005151 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-051-51) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-051-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/86d8848b-111b-4da9-8957-7cccef1b8f66
Use it
Look up 61755-051 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61755-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61755-051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.